Molecular mechanism and research progress of traditional Chinese medicine in the treatment of prostate cancer

被引:0
作者
Wang, Hai-Luo [1 ]
Zhang, Ruo-Ran [2 ]
Wang, Hao [1 ]
Xu, Peng [2 ]
Wang, Jing-Kai [2 ]
Chen, Bo [1 ]
Xu, Hao [3 ]
Pan, Deng [3 ]
Ma, Yu-Yang [3 ]
Pang, Kun [1 ,4 ,5 ]
机构
[1] Xuzhou Cent Hosp, Xuzhou Clin Sch, Xuzhou Med Coll, Dept Endocrinol, Xuzhou 221009, Jiangsu, Peoples R China
[2] Jiangsu Univ, Grad Sch, Zhenjiang 212013, Peoples R China
[3] Bengbu Med Univ, Bengbu, Anhui, Peoples R China
[4] Peixian Peoples Hosp, Dept Urol, Xuzhou, Jiangsu, Peoples R China
[5] Xuzhou Med Coll, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Urol, 199 South Jiefang Rd, Xuzhou, Jiangsu, Peoples R China
基金
中国博士后科学基金;
关键词
traditional Chinese medicine; prostate cancer; Chinese herbal medicine; physical therapy; NF-KAPPA-B; ANDROGEN RECEPTOR; HOT FLASHES; IN-VITRO; ANTITUMOR-ACTIVITY; WNT/BETA-CATENIN; DOWN-REGULATION; CELLS; CURCUMIN; APOPTOSIS;
D O I
10.53388/TMR20240514002
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Prostate cancer (PCa) is one of the most common malignant tumors in the male genitourinary system, ranking second in incidence worldwide. Traditional Chinese medicine (TCM), as an important component of complementary and alternative medicine, shows unique advantages in cancer treatment. Chinese herbal medicine is usually composed of multiple ingredients and involves multiple signaling pathways, which showed function of inducing apoptosis of cancer cells, arresting the cell cycle, inhibiting invasion and metastasis, reducing drug resistance, and regulating immune function. Physical therapy is also an important treatment of TCM. Currently, Physical therapy such as acupuncture or Tai Chi and Qigong are gaining increased recognition in the management of PCa, particularly in addressing issues like urinary incontinence and bone metastasis-related pain. This article reviews the TCM treatment and therapy of PCa, in order to provide new research avenues and treatment options for the treatment of PCa with TCM and improve the quality of life of patients.
引用
收藏
页码:18 / 18
页数:1
相关论文
共 107 条
[1]   Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer [J].
Abd Wahab, Nurul Azwa ;
Lajis, Nordin H. ;
Abas, Faridah ;
Othman, Iekhsan ;
Naidu, Rakesh .
NUTRIENTS, 2020, 12 (03)
[2]   Acupuncture for Hot Flashes in Patients With Prostate Cancer [J].
Beer, Tomasz M. ;
Benavides, Maria ;
Emmons, Sandra L. ;
Hayes, Margaret ;
Liu, Guohui ;
Garzotto, Mark ;
Donovan, Deirdre ;
Katovic, Nina ;
Reeder, Caron ;
Eilers, Kristine .
UROLOGY, 2010, 76 (05) :1182-1188
[3]   Predicting the risk of bone metastasis in prostate cancer [J].
Briganti, Alberto ;
Suardi, Nazareno ;
Gallina, Andrea ;
Abdollah, Firas ;
Novara, Giacomo ;
Ficarra, Vincenzo ;
Montorsi, Francesco .
CANCER TREATMENT REVIEWS, 2014, 40 (01) :3-11
[4]   Levels of fatigue and distress in senior prostate cancer survivors enrolled in a 12-week randomized controlled trial of Qigong [J].
Campo, Rebecca A. ;
Agarwal, Neeraj ;
LaStayo, Paul C. ;
O'Connor, Kathleen ;
Pappas, Lisa ;
Boucher, Kenneth M. ;
Gardner, Jerry ;
Smith, Sierra ;
Light, Kathleen C. ;
Kinney, Anita Y. .
JOURNAL OF CANCER SURVIVORSHIP, 2014, 8 (01) :60-69
[5]   Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway [J].
Cao, Hongwen ;
Feng, Yigeng ;
Sun, Peng ;
Chen, Lei ;
Wang, Dan ;
Gao, Renjie .
JOURNAL OF CANCER, 2023, 14 (12) :2246-2254
[6]   QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo [J].
Cao, Hongwen ;
Wu, Xiaotong ;
Gao, Renjie ;
Chen, Lei ;
Feng, Yigeng ;
Wang, Dan .
JOURNAL OF CANCER, 2023, 14 (12) :2236-2245
[7]   Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology [J].
Cao, Hongwen ;
Wang, Dan ;
Gao, Renjie ;
Li, Chenggong ;
Feng, Yigeng ;
Chen, Lei .
PEERJ, 2022, 10
[8]  
Cao HW, 2021, AGING-US, V13, P17202, DOI 10.18632/aging.203171
[9]   Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol [J].
Cao, Lu ;
Zhang, Xue ;
Cao, Fanfan ;
Wang, Ying ;
Shen, Yufan ;
Yang, Chunxin ;
Uzan, Georges ;
Peng, Bin ;
Zhang, Denghai .
BMC CANCER, 2015, 15
[10]   Targeting apoptosis in cancer therapy [J].
Carneiro, Benedito A. ;
El-Deiry, Wafik S. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (07) :395-417